Skip to main content

Johns Hopkins Genomics Center Using BioDiscovery's Microarray Software

NEW YORK (GenomeWeb News) – BioDiscovery said today that the Johns Hopkins Medical Institute has acquired a multi-seat license to Nexus Expression, a software package designed for microarray gene expression analysis.
The software is a platform-independent product that supports Affymetrix, Agilent, Illumina, Roche NimbleGen, and custom arrays, the company said.
The Nexus software provides functional annotation and enrichment analysis, gene set analysis, and it allows user input of gene lists for signature analysis, according to Chris Cheadle, director of the Johns Hopkins Lowe Family Genomics Core at Bayview Medical Center.
The software allows users to cluster genes and samples to discover expression patterns, compare expression profiles alongside gene annotations, display genes in affected biological processes, perform enrichment analysis, and identify genes that are significantly over-represented in a population, the company said.
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.